This $384,558 Project Grant award from the National Institutes of Health's (NIH) Child Health and Human Development Extramural Research program (CFDA 93.865) supports the development and evaluation of the "SenseWand" - a wireless pelvic floor diagnostic system (device and app) to assess pelvic floor muscle health using Electrical Impedance Myography (EIM). The recipient, Bold Type LLC, is a minority-owned, small disadvantaged business developing innovative medical devices and...
This Project Grant award of $550,000 from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program will fund the development of a catheter monitoring system to reduce peritoneal dialysis (PD) infections. The project, led by The Johns Hopkins University, aims to develop a medical device that enables real-time, continuous, and quantitative monitoring of biomarkers relevant to PD-associated infections. This will involve optimizing the optical and flow...
This federal Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), provides $1,749,465.00 to Bright Uro, Inc. to develop a catheter-free, extended-monitoring urodynamics device for quantitative, real-time bladder management in spinal cord-injured patients. The award period runs from July 1, 2024 to June 1, 2026. The goal of this project is to create an innovative medical device that can assist in the care and treatment...
Acatechol, Inc. was awarded a $274,982 National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant to develop an innovative anti-infective coating for Foley catheters. The project aims to create a hybrid coating that combines biofilm-repellent and antimicrobial properties to provide prolonged resistance against pathogen colonization and catheter-associated urinary tract infections (CAUTIs). This work is being conducted under the NSF Technology, Innovation, and...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $238,943 to Duke University to develop an automated platform for accurately tracking urine output in hospitalized heart failure patients. The key objectives are to: 1) validate the accuracy and timeliness of the device in measuring urine volume compared to conventional methods; 2) quantify the reduction in time lag between patient urination...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the CFDA program "Discovery and Applied Research for Technological Innovations to Improve Human Health" (93.286), provides $206,132 to the University of Houston System to develop a wireless, battery-free bioelectronic implant that enables continuous monitoring and autonomous electrical stimulation through a closed-loop artificial intelligence (AI) system. The goal is...
The University of North Carolina at Chapel Hill received a $100,000 Project Grant award from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a digital therapeutic device and mobile application for patients with high-tone pelvic floor disorders. The award will support the creation of an interactive pelvic wand and accompanying smartphone app to enable patients to conduct targeted pelvic floor muscle physical therapy...
The Spinex Inc. was awarded a $4,719,091 Project Grant from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases to develop and clinically validate a transcutaneous electrical spinal cord neuromodulation (TESCON) device to mitigate symptoms of neurogenic bladder resulting from spinal cord injury. The award, made under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support Spinex in building a commercial...
The National Institute of Child Health and Human Development (NICHD) awarded a $295,907 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Liberating Technologies Inc. (LTI) to develop a prototype "Unintrusive Pediatric Logging Orthosis Analytic Device (UPLOAD)." The goal is to create a commercially viable, unobtrusive remote monitoring system for pediatric orthotics that can improve compliance tracking. Key features include long battery life, low...
This Project Grant award of $412,250 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund the development of a continuous, real-time, automated smart catheter analyzer to enable early identification of sepsis through urine biomarkers. The primary goal is to create a device that can quickly diagnose sepsis, a life-threatening condition, without requiring invasive blood tests. The 2-year R61 (Phase I) project will...